1151240-89-9

Basic information

• Product Name: (S)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate
• Synonyms: (S)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate;2-Butenoic acid, 3-aMino-4-(2,4,5-trifluorophenyl)-, ethyl ester, (2Z)-
• CAS NO: 1151240-89-9
• Molecular Formula: C₁₂H₁₂F₃NO₂
• Molecular Weight: 245.1978096
• EINECS: -0
• Mol File: 1151240-89-9.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate(1151240-89-9)
• EPA Substance Registry System: (S)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate(1151240-89-9)

Safety Data

• Hazardous Substances Data: 1151240-89-9(Hazardous Substances Data)

Usage

General Description

(S)-Methyl 3-amino-4-(2,4,5-trifluorophenyl)but-2-enoate is a chemical compound with the molecular formula C11H10F3NO2. It is classified as an amino acid derivative and contains a fluorinated benzene ring. (S)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate is commonly used in pharmaceutical research and development due to its potential biological activity. It has been studied for its anti-inflammatory and analgesic properties, and it may have applications in the treatment of various medical conditions. Additionally, it is used as a building block in the synthesis of other complex organic molecules. Overall, (S)-Methyl 3-amino-4-(2,4,5-trifluorophenyl)but-2-enoate has significant potential for various scientific and industrial applications.

Upstream product

• 220141-74-2 2-(2,4,5-trifluorophenyl)acetonitrile 
• 105-36-2 ethyl bromoacetate 
• 1152439-73-0 2,2-dimethyl-5-[2-(2,4,5-trifluorophenyl)acetyl]-[1,3]dioxane-4,6-dione 
• 209995-38-0 (2,4,5-trifluorophenyl)acetic acid 
• 1151240-88-8 3-oxo-4-(2,4,5-trifluorophenyl)-butyric acid ethyl ester 

Downstream Products

• 1151240-91-3 (3R)-3-amino-4-(2,4,5-trifluorophenyl)butyric acid ethyl ester 
• 1151240-92-4 ethyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate 
• 1151240-90-2 (S)-ethyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate 
• 1152439-74-1 (R)-3-tertbutoxycarbonylamino-4-(2,4,5-trifluorophenyl)butyric acid ethyl ester 
• 486460-00-8 (3R)-3-[(1,1-dimethylethoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic acid 
• 1152439-77-4 (R)-[3-oxo-1-(2,4,5-trifluorobenzyl)-3-(3-trifluoromethyl-5,6-dihydro-8H-imidazo[1,5-a]pyrazin-7-yl)-propyl]-carbamic acid t-butyl ester 
• 1152440-32-8 (R)-[3-oxo-1-(2,4,5-trifluorobenzyl)-3-(1-bromo-3-trifluoromethyl-5,6-dihydro-8H-imidazo[1,5-a]pyrazin-7-yl)-propyl]-carbamic acid t-butyl ester 
• 1174039-18-9 (R)-7-[3-tertbutoxycarbonylamino-4-(2,4,5-tri-fluorophenyl)butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylic acid methyl ester 
• 1174039-19-0 (R)-7-[3-tertbutoxycarbonylamino-4-(2,4,5-tri-fluorophenyl)butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylic acid 
• 1242332-75-7 (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo [1,5-a]pyrazine-1-carboxylic acid choline salt 
• 1242332-69-9 (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo [1,5-a]pyrazine-1-carboxylic acid triethyl amine salt 
• 1242332-84-8 (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo [1,5-a]pyrazine-1-carboxylic acid-(2S)-2-amino-5-carbamimidamidopentanoic acid 
• 1242332-81-5 (R)-7-[3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylic acid (2S,3S)-2,3-dihydroxybutanedioic acid 
• 1242332-77-9 (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo [1,5-a]pyrazine-1-carboxylic acid (2S)-malic acid salt 

Relevant articles and documents

Preparation method of phenyl crotonic acid ester compound

The invention relates to the technical field of organic synthesis, in particular to a preparation method of a phenyl crotonate compound, the preparation method comprises the following steps: S1, carrying out Willgerodt-Kindler reaction on an acetophenone

TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES SALTS, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF

The present invention relates to (R)-7-[3-Amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylic acid pharmaceutical salts, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as a dipeptidyl peptidase IV inhibitor.

TETRAHYDRO-IMIDAZO[1,5-a]PYRAZINE DERIVATIVES SALTS, PREPARATION METHODS AND MEDICINAL USE THEREOF

Pharmaceutically acceptable salts of (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-formic acid, their preparation methods, compositions containing the said pharmaceutical salts and their use as medicaments, especially as dipeptidyl peptidase IV (DPP-IV) inhibitors are disclosed.